Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,590.20
+5.40 (0.34%)
Jun 6, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 448.76 billion as of June 6, 2025. Its market cap has increased by 55.98% in one year.
Market Cap
448.76B
Enterprise Value
456.43B
Revenue
134.35B
Ranking
n/a
PE Ratio
42.86
Stock Price
1,590.20
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 448.76B, an increase of 38,945.89%. That is a compound annual growth rate of 28.21%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,994.65B |
| Divi's Laboratories | 1,756.87B |
| Cipla | 1,188.77B |
| Apollo Hospitals Enterprise | 985.64B |
| Mankind Pharma | 973.57B |
| Zydus Lifesciences | 937.31B |
| Aurobindo Pharma | 661.36B |
| Alkem Laboratories | 582.10B |